Surfactant composition reflects lung overinflation and arterial oxygenation in patients with acute lung injury

European Respiratory Journal

Volumn 12, Issue 2, 1998, Pages 301-308

  Bersten, A D ^a,b   Doyle, I R ^a   Davidson, K G ^a   Barr, H A ^a   Nicholas, T E ^a   Kermeen, F ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Lung function; Respiratory mechanics; Surfactant phospholipids; Surfactant proteins A and B

Indexed keywords

OXYGEN; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PROTEIN A; SPHINGOMYELIN; SURFACTANT; UREA;

ARTERIAL OXYGEN SATURATION; ARTERIAL OXYGEN TENSION; ARTICLE; CLINICAL ARTICLE; COMPLIANCE (PHYSICAL); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LUNG INFLATION; LUNG INJURY; LUNG VOLUME; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL;

EID: 0031814132     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.12020301     Document Type: Article

References (33)

1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967; 2: 319-323.
2. Gregory TJ, Longmore WJ, Moxley MA, et al. Surfactant composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991; 88: 1976-1981.
3. Pison U, Seeger W, Buchhorn R, et al. Surfactant abnormalities in patients with respiratory failure after multiple trauma. Am Rev Respir Dis 1989; 140: 1033-1039.
4. Pison U, Obertake U, Brand M, et al. Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of acute respiratory failure. J Trauma 1990; 30: 19-26.
5. Hallman M, Spragg R, Harrell JH, Moser KM, Gluck L. Evidence of lung surfactant abnormality in respiratory failure - study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J Clin Invest 1982; 70: 673-683.
6. Gunther A, Siebert C, Schmidt R, et al. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 1996; 153: 176-184.
7. Pison U, Obertacke U, Seeger W, Hawgood S. Surfactant protein A (SP-A) is decreased in acute parenchymal lung injury associated with polytrauma. Eur J Clin Invest 1992; 22: 712-718.
8. Radford EP. Recent studies of mechanical properties of mammalian lungs. In: Remington JW, ed. Tissue Elasticity. Washington, DC, Am Physiol Soc, 1957; pp. 177-190.
9. Doyle IR, Nicholas TE, Bersten AD. Serum surfactant protein-A levels in patients with acute cardiogenic pulmonary edema and adult respiratory distress syndrome. Am J Respir Crit Care Med 1995; 152: 307-317.
10. Doyle IR, Bersten AD, Nicholas TE. Surfactant proteins-A & -B are elevated in plasma of patients with acute respiratory failure. Am J Respir Crit Care Med 1997; 156: 1217-1229.
11. Doyle IR, Jones ME, Orgeig S, et al. The ratio of surfactant protein A (SP-A), cholesterol and disaturated phospholipid in human surfactant varies with level of fitness and exercise. Am J Respir Crit Care Med 1994; 149: 1619-1627.
12. Kano S, Lanteri CJ, Duncan AW, Sly PD. Influence of nonlinearities on estimates of respiratory mechanics using multilinear regression analysis. J Appl Physiol 1994; 77: 1185-1197.
13. Pison U, Gono E, Joka T, Obertacke U, Obladen M. High-performance liquid chromatography of adult human bronchoalveolar lavage: assay for phospholipid lung profile. J Chromatogr 1986; 377: 79-89.
14. Holter JF, Weiland JE, Pacht ER, Gadek JE, Davis WB. Protein permeability in the adult respiratory distress syndrome: loss of size selectivity of the alveolar epithelium. J Clin Invest 1986; 78: 1513-1522.
15. Pelosi P, D'Andrea L, Vitale G, Pesenti A, Gattinoni L. Vertical gradient of regional lung inflation in adult respiratory distress syndrome. Am J Respir Crit Care Med 1994; 149: 8-13.
16. Clark JG, Milberg JA, Steinberg KP, Hudson LD. Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death. Ann Intern Med 1995; 122: 17-23.
17. Chestnutt AN, Matthay MA, Tibayan FA, Clark JG. Early detection of type III procollagen peptide is present in acute lung injury: pathogenetic and prognostic significance. Am J Respir Crit Care Med 1997; 156: 840-845.
18. Pittet JF, Mackersie RC, Martin TR, Matthay MA. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med 1997; 155: 1187-1205.
19. Bernhard W, Haagsman HP, Tschernig T, et al. Conductive airway surfactant: surface-tension function, biochemical composition, and possible alveolar origin. Am J Respir Cell Mol Biol 1997; 117: 41-50.
20. Wilkinson A, Jenkins PA, Jeffrey JA. Two trials of dry artificial surfactant: early effects and later outcome in babies with surfactant deficiency. Lancet 1985; 2: 287-291.
21. Hallman M, Merritt TA, Pohjavuori M, Gluck L. Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure. Pediatr Res 1986; 20: 1228-1235.
22. Gerdes J, Whitsett J, Long W. Elastase activity and surfactant protein concentration in tracheal aspirates from neonates receiving synthetic surfactant. J Pediatr 1992; 120: S34-S39.
23. LeVine AM, Lotze A, Stanley S, et al. Surfactant content in children with inflammatory lung disease. Crit Care Med 1996; 24: 1062-1067.
24. Jacobson W, Park GR, Saich T, Holcroft J. Surfactant and adult respiratory distress syndrome. Br J Anaesth 1993; 70: 522-526.
25. Doyle IR, Davidson KG, Payne K, Barr HA, Pfitzner J, Nicholas TE. Quantity and structure of surfactant proteins vary in patients with alveolar proteinosis. Am J Respir Crit Care Med 1998; 157: 658-664.
26. Gluck LM, Kulovich MV, Borer RC, Brenner PH, Anderson GG, Spellacy WN. The interpretation and significance of the lecithin/sphingomyelin ratio in amniotic fluid. Am J Obstet Gynecol 1974; 120: 142-155.
27. Neumann MA, McMurchie EJ, Gibson RA. A comparison of lung lamellar body phospholipids from premature and term infants: is sphingomyelin a contaminant of surfactant? Pediatr Pulmonol 1990; 9: 162-165.
28. 2 levels: correlation with the hemodynamic and pulmonary changes in Gram-negative septic shock. J Lab Clin Med 1984; 104: 873-881.
29. Holm BA, Keicher L, Liu M, Sokolowski J, Enhorning G. Inhibition of pulmonary surfactant by phospholipases. J Appl Physiol 1991; 71: 317-321.
30. Niewwoehner DE, Rice K. Injurious effects of lysophosphatidylcholine on barrier effects of alveolar epithelium. J Appl Physiol 1987; 63: 1979-1986.
31. Nakos G, Pneumatikos J, Tsangaris I, Tellis C, Lekka M. Proteins and phospholipids in BAL from patients with hydrostatic pulmonary edema. Am J Respir Crit Care Med 1997; 155: 945-951.
32. Bunnell E, Pacht ER. Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1993; 148: 1174-1178.
33. Peterson BT, Idell S, Macarthur C, Gray LD, Cohen AB. A modified bronchoalveolar lavage procedure that allows measurement of lung epithelial lining fluid volume. Am Rev Respir Dis 1990; 141: 314-320.